Leadership Overview
Kite Pharma has 4 executives leading key functions including strategy, operations, and commercial execution.
Driven by a commitment to patient access, Kite Pharma advances cell therapy to treat and potentially cure cancer, reengineering patient immune cells to combat malignancies and establishing a significant impact in cancer immunotherapy.
Driven by a commitment to patient access, Kite Pharma advances cell therapy to treat and potentially cure cancer, reengineering patient immune cells to combat malignancies and establishing a significant impact in cancer immunotherapy.
Leadership Roles at Kite Pharma
Neda Swisher - Deputy Chief Operating Officer
Neda Swisher, the Deputy Chief Operating Officer at Kite Pharma, drives operational excellence across the company's global manufacturing and supply chain for its pioneering cell therapies. Swisher oversees the complex processes involved in reengineering patient immune cells, ensuring the highest standards of quality and efficiency in treatments for hematologic malignancies. This critical role supports Kite Pharma's commitment to making advanced cancer immunotherapies accessible to eligible patients worldwide. Neda Swisher's leadership focuses on scaling operations to meet growing demand while maintaining the integrity of the specialized manufacturing facilities located in the United States and the Netherlands. By optimizing operational workflows and resource management, Swisher directly contributes to the company's ability to deliver potentially curative treatments and solidify its impact in the pharmaceutical industry.
Leslie Millington - Senior Director, Business Strategy & Operations Chief of Staff
Leslie Millington, the Senior Director, Business Strategy & Operations Chief of Staff at Kite Pharma, directs strategic initiatives and operational execution. Millington ensures alignment between high-level business objectives and day-to-day functional activities, supporting the company's mission to make innovative cell therapies accessible. This leadership role involves optimizing internal processes and resource allocation to facilitate the complex manufacturing of engineered T cell therapies. Millington's oversight extends to critical operational frameworks that underpin Kite Pharma's advancements in hematologic malignancy treatments. The focus remains on driving efficiency and strategic coherence across the organization, directly contributing to the company's market impact in cancer immunotherapy. By managing key operational projects, Leslie Millington enhances the company's capacity to deliver life-changing treatments to eligible patients.
Rachel Hodge - Senior Director, Business Strategy & Global Operations, To The Head of Commercial Chief of Staff
Rachel Hodge, the Senior Director, Business Strategy & Global Operations, To The Head of Commercial Chief of Staff at Kite Pharma, spearheads strategic planning and global operational frameworks within the commercial division. Hodge ensures seamless integration of business strategy with global operational execution, directly supporting Kite Pharma's commitment to patient access for its pioneering cell therapies. This role involves refining commercial operations to enhance the delivery of treatments for hematologic malignancies. By managing key strategic projects, Rachel Hodge strengthens the company's ability to scale its specialized cancer immunotherapy treatments. The focus is on driving operational excellence across international markets, ensuring that Kite Pharma's innovative reengineered T cell therapies reach eligible patients efficiently. Hodge's leadership ensures that commercial strategies are robustly supported by agile and effective global operations, solidifying Kite Pharma's position in the pharmaceutical landscape.
Kristen Draves - Director, Head of Business Strategy and Operations. Chief of Staff
Kristen Draves, the Director, Head of Business Strategy and Operations. Chief of Staff at Kite Pharma, architects business strategy and operational frameworks to advance the company's mission. Draves focuses on enhancing the efficiency and effectiveness of Kite Pharma's cell therapy manufacturing and distribution processes, critical for treating hematologic malignancies. This leadership position involves translating strategic visions into actionable operational plans, ensuring that the reengineering of patient immune cells is managed with precision. Kristen Draves drives initiatives that support the accessibility of these innovative cancer treatments to eligible patients. The operational oversight extends to optimizing resource deployment and streamlining workflows across Kite Pharma's specialized facilities. By aligning business strategy with operational execution, Draves significantly contributes to the company's ongoing advancements in cancer immunotherapy and its market presence.
Explore Leadership Teams in Manufacturing
Founded in 1974, Apotex is a proud Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world.
Company Leadership
TM
CV
MG
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.
Company Leadership NL
NB
LTS Lohmann Therapie-Systeme AG is a pharmaceutical technology company that specializes in developing and manufacturing advanced drug delivery systems for the global healthcare industry. The company focuses on innovative ways to administer medicines through the skin, mouth, and other non-invasive routes, enabling more effective, patient-friendly, and controlled therapies. Its core expertise lies in technologies such as transdermal patches that deliver drugs through the skin, oral thin films that dissolve quickly in the mouth for rapid absorption, and microarray patch systems that use microscopic structures to deliver active ingredients into the skin in a minimally invasive manner. LTS also develops wearable injection devices and topical patch systems designed to improve convenience, adherence, and treatment outcomes for patients with chronic and complex medical conditions. The company operates as a contract development and manufacturing partner for pharmaceutical organizations, supporting the entire lifecycle of drug delivery solutions from early-stage development and formulation to large-scale production and commercialization. By combining scientific research, engineering capabilities, and industrial manufacturing, LTS enables its partners to bring new therapies to market more efficiently while improving patient experience and compliance. Its technologies are used in a wide range of therapeutic areas, including pain management, neurological disorders, hormone therapies, and other chronic conditions that require sustained or controlled drug release. With a global presence across Europe, North America, and Asia, LTS maintains production facilities, research centers, and commercial operations that support international pharmaceutical partners. The company emphasizes innovation, quality, and regulatory compliance, and continuously invests in new delivery technologies such as microneedle systems and wearable drug delivery platforms to expand future treatment possibilities. Through its integrated approach, LTS ...
Company Leadership AY
SS
Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines.
Company Leadership
HA
MB
AS
Frequently Asked Questions Regarding Kite Pharma Top Executives and Leadership Team
Unlock more people and company data
